A groundbreaking therapy, retatrutide, is generating significant buzz within the weight-loss community as a potential breakthrough for stubborn weight problems. This unique drug, a dual receptor targeting GLP-1 and GIP, appears to demonstrate impressive efficacy in clinical studies, potentially contributing to substantial weight reduction beyond wh